You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
GenomeWeb Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.
In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.
The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.
The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.
Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.
The composition of the immune infiltrate in the human tumor microenvironment is a critical determinant of disease progression.
As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before.
In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.